Article PDF
References
Fuster, V., Badimon, L., Badimon, J.J. & Chesebro, H.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). New Engl. J. Med. 326, 242–250 (1992).
Nordøy, A. Haemostatic factors in coronary heart disease. J. intern Med. 233, 377–383 (1993).
Vaziri, N.D., Kennedy, S.C., Kennedy, D. & Gonzales, E., oagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris. Am. J. Med. 93, 651–657 (1992).
Dahlbäck, B., Carlsson, M. & Svensson, P.J. Familial thrombophilia due to a previously unrecognized mechanism characterized by a poor anticoagulant response to activated protein C: prediction of a co-factor to activated protein C. Proc natn Acad. Sci. U.S.A. 90, 1004–1008 (1993).
Koster, T. et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet, 342, 1503–1506 (1993).
Bertina, R.M. et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64–67 (1994).
Zöller, B. & Dahlbäck, B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 343, 1536–1538 (1994).
Voorberg, J. et al. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet 343, 1535–1536 (1994).
Holm, J. et al. Myocardial infarction associated with homozygous resistance to activated protein C. Lancet 344, 952–953 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Bockxmeer, F., Baker, R. & Taylor, R. Premature ischaemic heart disease and the gene for coagulation factor V. Nat Med 1, 185 (1995). https://doi.org/10.1038/nm0395-185
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0395-185